ELECTROMEDICAL TECHNOLOGIES, INC. (EMED)

Every figure this model derived for EMED, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-09-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 149,705 PaymentsToAcquirePropertyPlantAndEquipment 2023-12-31
cash 34,809 CashAndCashEquivalentsAtCarryingValue 2024-09-30
current assets 305,361 AssetsCurrent 2024-09-30
current liabilities 4,355,847 LiabilitiesCurrent 2024-09-30
equity -4,004,762 StockholdersEquity 2024-09-30
interest expense 22,939 InterestPaidNet 2024-09-30
ocf -131,211 NetCashProvidedByUsedInOperatingActivities 2024-09-30
revenue 570,415 RevenueFromContractWithCustomerIncludingAssessedTax 2024-09-30
sbc 715,000 ShareBasedCompensation 2023-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up EMED on one particular measure came for.

RatioValue
cash operating margin-51.84
current ratio0.09
current ratio reported0.07
deferred revenue growth487.34
dilution pct182.56
fcf margin-49.25
growth cv1.06
interest cover-44.06
operating margin-177.19
owner earnings margin-174.59
revenue growth-42.8
revenue growth per share-79.76
rule of 40-219.99
sbc pct revenue125.35

What to be careful about

What this model itself distrusts about EMED's figures. Written by the derivation as it ran, not added afterwards.